Abbott Laboratories

Type: Company
Name: Abbott Laboratories
Nationality: United States
First reported 15 hours ago - Updated 15 hours ago - 1 reports

Global Transcriptomics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and Thermo Fisher Scientific

/PRNewswire/ --Research and Markets  ( http://www.researchandmarkets.com/research/j8jfz4/global ) has announced the addition of the  "Global Transcriptomics Market 2014-2018"  report to their offering.Transcriptomics studies involve the collection and ... [Published CW Atlanta - 15 hours ago]
First reported Sep 19 2014 - Updated 16 hours ago - 1 reports

Lt. Gov. Taylor points to Ohio’s job creation

Republican state leaders have made Ohio’s economy rebound quicker than other states, Lt. Gov. Mary Taylor says.“If you look at Ohio and where we are, wages are increasing, everything is increasing faster, obviously, in Ohio,” Taylor said Thursday during ... [Published Findlay Courier - Sep 19 2014]
First reported Sep 18 2014 - Updated 21 hours ago - 1 reports

Traders go gaga over BABA - The Buzz

Traders can't wait to buy Alibaba's stock ... and they are expressing their excitement on social media.The opinions expressed in this commentary are solely those of Paul R. La Monica. Other than Time Warner, the parent of CNNMoney, Abbott Laboratories ... [Published DailyMe.Com - Sep 18 2014]
First reported Sep 18 2014 - Updated 22 hours ago - 1 reports

Artificial Sweeteners May Contribute to Metabolic Disorders

Table Sweeteners Becky Stern/flickr> Artificial sweeteners are a roughly $1.5 billion industry worldwide , often marketed as helpful for managing obesity and diabetes. But some new research suggests sugar substitutes could actually contribute ... [Published Popular Science - New Technology, Science News, ... - Sep 18 2014]
First reported Sep 18 2014 - Updated Sep 18 2014 - 1 reports

UK: Gemini International wins global pharma contract

By: CAT PublicationsGemini International has won the contract to join Abbott Laboratories ' new Meetings and Events Network.The Cheshire-based agency is one of three to join the healthcare company's roster after a four-month procurement process.The win ... [Published International Meetings Review - Sep 18 2014]
First reported Sep 18 2014 - Updated Sep 18 2014 - 1 reports

Abbott Laboratories Receives Average Rating of “Hold” from Brokerages (NYSE:ABT)

Shares of Abbott Laboratories (NYSE:ABT) have been given an average rating of "Hold" by the fifteen brokerages that are presently covering the company, . Two analysts have rated the stock with a sell recommendation, five have assigned a hold recommendation ... [Published American Banking News - Sep 18 2014]
First reported Sep 18 2014 - Updated Sep 18 2014 - 2 reports

ABBOTT LABORATORIES : An Application for the Trademark "ABBOTT MOBILE HEALTH" Has Been Filed by Abbott Laboratories

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C. , by NewsRx journalists, a trademark application has been made for "ABBOTT MOBILE HEALTH" by Michele H. Bowman , representing ... [Published 4 Traders - Sep 18 2014]
First reported Sep 18 2014 - Updated Sep 18 2014 - 1 reports

Investment Analysts’ Ratings Reiterations for September, 17th (ABT, ACQ, ATVI, AZN, BRK, CGX, GSK, GWRE, JHX, MWG)

Investment Analysts’ ratings reiterations for Wednesday, September 17th:Abbott Laboratories (NYSE:ABT) had its neutral rating reiterated by analysts at Zacks . Zacks currently has a $45.00 price target on the stock. Zacks’ analyst wrote, “Abbott reported ... [Published Mideast Time - Sep 18 2014]
First reported Sep 17 2014 - Updated Sep 17 2014 - 1 reports

Potential Abbott Laboratories (ABT) Trade Targets 4.99% Return

Tuesday’s trading in Abbott Laboratories (ABT) gives options traders an opportunity for a 19.84% return. By selling the Jan. '15 $44.00 call and buying the Jan. '16 call at the $35.00 level for a net debit of $7.51, traders will book a profit as long ... [Published MarketIntelligenceCenter.com - Sep 17 2014]
First reported Sep 16 2014 - Updated Sep 17 2014 - 2 reports

Gemini International wins global pharma contract

Gemini International has won the contract to join Abbott Laboratories' new Meetings and Events Network.The Cheshire-based agency is one of three to join the healthcare company's roster after a four-month procurement process.The win sees Gemini International ... [Published Meetpie - Sep 17 2014]
First reported Sep 15 2014 - Updated Sep 16 2014 - 2 reports

Abbott Labs Presents Positive One-Year Data on Absorb - Analyst Blog

The data from the trial showed that patients treated with Absorb experienced a significantly lower rate of angina (chest pain) compared to those treated with the Xience family of DES.We note that Absorb obtained the CE mark in Europe in Jan 2011 but is ... [Published Nasdaq - Sep 16 2014]
First reported Sep 14 2014 - Updated Sep 15 2014 - 4 reports

Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device

ABBOTT PARK, Ill., Sept. 15, 2014 /PRNewswire/ -- Abbott announced today the start of the ABSORB IV clinical trial, which will test whether its Absorb Bioresorbable Vascular Scaffold (BVS) is more cost-effective and offers a higher quality of life than ... [Published The CW44 Tampa Bay - Sep 15 2014]

Quotes

...The director in charge further says: "Affluent patients from across the globe are willing to travel to find the best hospitals and healthcare facilities. The UAE offers a world-class service in terms of availability and quality, and is easily accessible to the rest of the world thanks to its airline and airport infrastructure. The Dubai Health Care City is providing a platform for increased medical tourism and will bring more revenue to Dubai and the UAE, driving market growth at a much faster rate than historically."
Original Article: NEXT ARTICLE More From BioPortfolio on "Hesitation In The Medical Device ETF: Just A Bump In The Road?"
...That'll put AbbVie into competition with Gilead Sciences " breakout hep-C star, Sovaldi, which has reeled in nearly $6 billion through the first half of 2014. With debate raging over Sovaldi's pricing, there's a huge opportunity for AbbVie to capitalize in an HCV market that could eclipse $20 billion annually within this decade."
...It makes what I do interesting to those at our dinner table, notwithstanding that I'm not "a real lawyer who, you know, goes to court and stuff."

More Content

All (1130) | News (799) | Reports (1) | Blogs (298) | Audio/Video (1) | Fact Sheets (10) | Press Releases (20)
sort by: Date | Relevance
Follow-up of Blood-Pressure Lowering and Glucos... [Published New England Journal of Medicine - 3 hours ago]
ReportsnReports Releases Report on UAE Pharmace... [Published Insurance News Net - 6 hours ago]
Hesitation In The Medical Device ETF: Just A Bu... [Published BioPortfolio - 14 hours ago]
Global Transcriptomics Market 2014-2018: Key Ve... [Published CW Atlanta - 15 hours ago]
Hesitation In The Medical Device ETF: Just A Bu... [Published Seeking Alpha - 15 hours ago]
Delphinus appoints Mark J. Forchette president ... [Published Center Watch - 18 hours ago]
ICTP welcomes G.S.A.R. Marketing as new member [Published ETurboNews - 19 hours ago]
Bayer to spin out material science division [Published PMLive - 20 hours ago]
3 Best Stocks to Invest in Pharma [Published Motley Fool Discussion Boards - 22 hours ago]
Abbott Laboratories (ABT) Showing Bullish Techn... [Published MarketIntelligenceCenter.com - Sep 19 2014]
Bleck, Eugene E. [Published San Jose Mercury News - Sep 19 2014]
Marks and Spencer Ireland is overall winner at ... [Published Business & Leadership - Sep 19 2014]
National and Local News Briefs [Published San Francisco Bay Times - Sep 19 2014]
Global Molecular Cytogenetics Market 2014-2018:... [Published WorldNetDaily - Sep 19 2014]
Women Leaders in Tech Law: Jennifer Fonner Fitc... [Published Recorder - Sep 19 2014]
Lt. Gov. Taylor points to Ohio’s job creation [Published Findlay Courier - Sep 19 2014]
UK: Gemini International wins global pharma con... [Published International Meetings Review - Sep 18 2014]
Artificial Sweeteners May Contribute to Metabol... [Published Popular Science - New Technology, Science News, ... - Sep 18 2014]
Traders go gaga over BABA - The Buzz [Published DailyMe.Com - Sep 18 2014]
TRANSLATE-ACS: No MACE Benefit With Prasugrel i... [Published American Journal of Public Health - Sep 18 2014]
Put a lid on 'Low-T' drug use, FDA panel advise... [Published FiercePharma - Sep 18 2014]
China Human Vaccine Industry Report 2014-2017 [Published SBWire - Sep 18 2014]
Abbott Laboratories Receives Average Rating of ... [Published American Banking News - Sep 18 2014]
Abbott Laboratories (ABT) Showing Support Near ... [Published MarketIntelligenceCenter.com - Sep 18 2014]
POCT Market in China : 2014-2018 [Published MarketResearch.com - Sep 18 2014]
Prebiotics Market Trends and Strategic Focus Re... [Published MyNewsDesk - Sep 18 2014]
Time to cull this plague of dunces [Published Spectator - Sep 18 2014]
ABBOTT LABORATORIES : An Application for the Tr... [Published 4 Traders - Sep 18 2014]
Abbott Laboratories : ' Trademark Application f... [Published 4 Traders - Sep 18 2014]
Investment Analysts’ Ratings Reiterations for S... [Published Mideast Time - Sep 18 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Abbott Laboratories (ABT) Showing Bullish Techn... [Published MarketIntelligenceCenter.com - Sep 19 2014]
MarketIntelligenceCenter.com’s patented algorithms have chosen the Nov. '14 $44.00 call for a couple of hedged-trading ideas on Abbott Laboratories (ABT). A traditional covered call on Abbott Laboratories yields 2.78% (15.85% annualized, for comparison ...
Artificial Sweeteners May Contribute to Metabol... [Published Popular Science - New Technology, Science News, ... - Sep 18 2014]
Table Sweeteners Becky Stern/flickr> Artificial sweeteners are a roughly $1.5 billion industry worldwide , often marketed as helpful for managing obesity and diabetes. But some new research suggests sugar substitutes could actually contribute ...
Abbott Laboratories (ABT) Showing Support Near ... [Published MarketIntelligenceCenter.com - Sep 18 2014]
Abbott Laboratories (ABT) was identified by MarketIntelligenceCenter.com’s patented algorithms today after trading between $42.76 and $43.57 on Wednesday before closing at $43.38. A diagonal spread using a long position in the Jan. '16 $35.00 call and ...
Potential Abbott Laboratories (ABT) Trade Targe... [Published MarketIntelligenceCenter.com - Sep 17 2014]
Tuesday’s trading in Abbott Laboratories (ABT) gives options traders an opportunity for a 19.84% return. By selling the Jan. '15 $44.00 call and buying the Jan. '16 call at the $35.00 level for a net debit of $7.51, traders will book a profit as long ...
Research and Markets: Global Companion Diagnost... [Published Business Wire Health News - Sep 16 2014]
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/rcg9gj/companion) has announced the addition of the "Companion Diagnostics Market byTechnology, Application , & by End-user - Global Trends & Forecasts to 2019" ...
1 2 3 4 5 6 7 8 9 10 ...

Audio/Video

sort by: Date | Relevance
A Body Slam For WWE Stock [Published Wall Street Journal What's News - May 16 2014]
1

Press Releases

sort by: Date | Relevance
The Zacks Analyst Blog Highlights: Mylan, Abbot... [Published Financial Services - Sep 12 2014]
The Zacks Analyst Blog Highlights: Google, AbbV... [Published Financial Services - Sep 05 2014]
Favourable Rulings, Upcoming Conferences, Clini... [Published Financial Services - Sep 03 2014]
Collaborations, New Contract, Dividend Declarat... [Published Financial Services - Aug 26 2014]
Health Care Equipment Equities Ahead of Market ... [Published Financial Services - Aug 21 2014]
1 2 3 4
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.